Skip to main content

Find Clinical Trials

Home
Conditions
ER+, HER2-, Metastatic Breast Cancer

Clinical trial condition

ER+, HER2-, Metastatic Breast Cancer

Explore clinical trials studying ER+, HER2-, Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

ER+, HER2-, Metastatic Breast Cancer trial results

Not Yet Recruiting

Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer

NCT07729046

Conditions: Breast Diseases, Breast Neoplasms, ER+, HER2-, Metastatic Breast Cancer, +6 more
Locations: UC San Diego Health Moores Cancer Center La Jolla, California, United States

View Trial Details

Completed

AZD9833 China PK Study

NCT04818632

Conditions: Breast Diseases, Breast Neoplasms, ER+, HER2-, Metastatic Breast Cancer, +4 more
Locations: Research Site Beijing, China

Research Site Chengdu, China

Research Site Shanghai, China

Research Site Wuhan, China

View Trial Details